About Azilect^®

Azilect^® (rasagiline) is a therapy for Parkinson's disease that was first launched in 2005. Azilect^® (rasagiline) is available as 1mg tablets (EU and US) an MAO-B inhibitor and is given as a once daily, no titration dosing regimen. Azilect^® (rasagiline) can be used to treat the symptoms of Parkinson's disease in both early and moderate-to-advanced disease where it has been shown provide symptomatic benefits in these stages of the disease, and is generally well tolerated.

Please use the left hand menu to access more detailed information about Azilect^® (rasagiline) in Parkinson's disease.

References:

1. Azilect SmPC

Published: 14/03/2006   Last updated: 01/07/2011